GlassScriptPhysician profile
Alberto A Pena
NPI 1467407601
$58,622.04
in general payments reported to CMS, 2019-2025
15 companies · $1,654 in 2025
The $1,654 reported for 2025 was more than what 79% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,019 · 2020: $182 · 2021: $13K · 2022: $5,372 · 2023: $22K · 2024: $9,599 · 2025: $1,654.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $20K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,500 · Food and Beverage: $2,378 · Travel and Lodging: $2,330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $20,005.21 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,500.00 |
| Food and Beverage | $2,377.71 |
| Travel and Lodging | $2,329.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $56,299.25 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Axonics, INC. | $519.95 | 2022-2024 | Axonics |
| Medtronic USA, INC. | $353.40 | 2019-2020 | |
| Boston Scientific Corporation | $280.58 | 2025 | Axonics |
| Baxter Healthcare | $223.98 | 2021-2022 | |
| Medtronic, INC. | $202.96 | 2021 | |
| Davol INC. | $173.83 | 2021-2023 | Phasix Mesh |
| Mimedx Group, INC. | $114.70 | 2024 | |
| Becton, Dickinson and Company | $98.45 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $84.66 | 2022 | |
| Amgen INC. | $83.79 | 2023 | Otezla |
| Vifor Pharma, INC. | $78.94 | 2019 | |
| Mml US, INC. | $46.17 | 2025 | Reactiv8 |
| Conmed Corporation | $35.71 | 2023 | Airseal |
| Janssen Biotech, INC. | $25.67 | 2024 | Tremfya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alberto Pena listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.